Semler Scientific (SMLR) to Release Quarterly Earnings on Monday

Semler Scientific (NASDAQ:SMLR) is set to post its quarterly earnings results after the market closes on Monday, November 4th. Investors that are interested in participating in the company’s conference call can do so using this link.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.08. Semler Scientific had a return on equity of 21.17% and a net margin of 25.62%. The company had revenue of $14.47 million for the quarter.

Semler Scientific Stock Down 0.9 %

Shares of SMLR stock opened at $27.42 on Monday. The business has a fifty day simple moving average of $25.74 and a 200 day simple moving average of $28.46. The company has a market cap of $191.67 million, a P/E ratio of 13.44 and a beta of 0.96. Semler Scientific has a twelve month low of $20.88 and a twelve month high of $53.38.

Insiders Place Their Bets

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the sale, the chief executive officer now directly owns 60,220 shares in the company, valued at approximately $1,707,237. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 30.20% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.